Do you want to read an article? Please log in or register.
Increased monocyte count as a cellular biomarker for poor outcomes in fibrotic diseases: a retrospective, multicentre cohort study
Pulmonary Fibrosis
RECOMMENDED
Related content
RECOMMENDED
Interstitial Lung DiseasePulmonary Fibrosis
Survival after inpatient or outpatient pulmonary rehabilitation in patients with fibrotic interstitial lung disease: a multicentre retrospective cohort study
★ 3
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Thorax
Guler SA, Hur SA, Stickland MK, Brun P, Bovet L, Holland AE, Bondarenko J, Hambly N, Wald J, Makhdami N, Kreuter M, Gloeckl R, Jarosch I, Tan B, Johannson KA, McBride SA, De Boer K, Sandoz JS, Sun K, Assayag D, Bhatt SP, Morisset J, Ferraro V, Garvey C, Camp PG, Ryerson CJ
doi: 10.1136/thoraxjnl-2021-217361
RECOMMENDED
Pulmonary Hypertension
Pulmonary vascular resistance and clinical outcomes in patients with pulmonary hypertension: a retrospective cohort study
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Lancet Respir Med.
Maron BA, Brittan EL, Hess E, Waldo SW, Barón AE, Huang S, Goldstein RH, Assad T, Wertheim BM, Alba GA, Leopold JA, Olschewski H, Galiè N, Simonneau G, Kovacs G, Tedford RJ, Humbert M, Choudhary G
doi: 10.1016/S2213-2600(20)30317-9.
Pulmonary Fibrosis
An epithelial biomarker signature for idiopathic pulmonary fibrosis: an analysis from the multicentre PROFILE cohort study
Lancet Respir Med.
Maher TM, Oballa E, Simpson JK, Porte J, Habgood A, Fahy WA, Flynn A, Molyneaux PL, Braybrooke R, Divyateja H, Parfrey H, Rassl D, Russell AM, Saini G, Renzoni EA, Duggan AM, Hubbard R, Wells AU, Lukey PT, Marshall RP, Jenkins RG
doi: 10.1016/
Asthma
A retrospective cohort study in severe asthma describing commonly measured biomarkers: Eosinophil count and IgE levels
Respir Med.
Haughney J, Morice A, Blyth KG, Lee AJ, Coutts A, McKnight E, Pavord I
doi: 10.1016/j.rmed.2017.12.001.
RECOMMENDED
Pulmonary Fibrosis
Increased monocyte count and red cell distribution width as prognostic biomarkers in patients with Idiopathic Pulmonary Fibrosis
★ 1
Recommended by
Dr Martin Frey, Faculty Member
Respir Res
Karampitsakos T, Torrisi S, Antoniou K, Manali E, Korbila I, Papaioannou O, Sampsonas F, Katsaras M, Vasarmidi E, Papakosta D, Domvri K, Fouka E, Organtzis I, Daniil Z, Dimeas I, Kirgou P, Gourgoulianis KI, Papanikolaou IC, Markopoulou K, Kounti G, Tsapakidou E, Papadopoulou E, Tatsis K, Gogali A, Kostikas K, Tzilas V, Chrysikos S, Papiris S, Bouros D, Kreuter M, Tzouvelekis A
doi: 10.1186/s12931-021-01725-9
RECOMMENDED
Interstitial Lung Disease
Connective tissue disease-associated interstitial lung disease and outcomes after hospitalization: A cohort study
Respir Med.
Ratwani AP, Ahmad KI, Barnett SD, Nathan SD, Brown AW
doi: 10.1016/j.rmed.2019.05.020.
RECOMMENDED
Asthma
Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK
★ 3
Recommended by
Dr Martin Frey, Faculty Member
Lancet Respir Med
Bloom CI, Drake TM, Docherty AB, Lipworth BJ, Johnston SL, Nguyen-Van-Tam JS, Carson G, Dunning J, Harrison EM, Baillie JK, Semple MG, Cullinan P, Openshaw PJM, ISARIC investigators.
doi: 10.1016/S2213-2600(21)00013-8
RECOMMENDED
Pneumonia
Broad-spectrum antibiotic use and poor outcomes in community-onset pneumonia: a cohort study
Eur Respir J.
Webb BJ, Sorensen J, Jephson A, Mecham I, Dean NC
doi: 10.1183/13993003.00057-2019.
COMMENTED
Pulmonary Fibrosis
Monocyte Count as a Prognostic Biomarker in Patients with Idiopathic Pulmonary Fibrosis
★ 3
Recommended and commented by
Dr Martin Frey, Faculty Member
Am J Respir Crit Care Med
Kreuter M, Lee JS, Tzouvelekis A, Oldham JM, Molyneaux PL, Weycker D, Atwood M, Kirchgaessler KU, Maher TM
doi: 10.1164/rccm.202003-0669OC